Published pharmacoeconomic analyses: science or marketing?

被引：4

作者：

Henry, D ^{[1
]}

Lang, D ^{[1
]}

机构：

[1] Univ Newcastle, Sch Med Practice & Populat Hlth, Discipline Clin Pharmacol, Newcastle, NSW 2308, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2003年 / 33卷 / 9-10期

关键词：

D O I：

10.1046/j.1445-5994.2003.00473.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：403 / 404

页数：2

共 50 条

[11] Common Errors and Controversies in Pharmacoeconomic Analyses
Javier Soto
PharmacoEconomics, 1998, 14 (6) : 711 - 712
[12] SCIENCE OF MARKETING, AND MARKETING AS SCIENCE - INTRODUCTION
BONOMA, TV
ZALTMAN, G
AMERICAN BEHAVIORAL SCIENTIST, 1978, 21 (04) : 471 - 478
[13] The impact of the academy of marketing science on marketing scholarship: An analysis of the research published in JAMS (vol 24, pg 297, 1996)
Malhotra, NK
JOURNAL OF THE ACADEMY OF MARKETING SCIENCE, 1997, 25 (02) : 138 - 138
[14] SYSTEMATIC REVIEW OF PHARMACOECONOMIC STUDIES PUBLISHED IN ALGERIA, MOROCCO, AND TUNISIA
Mokhtar, M. A.
Messafeur, M. E. A.
Mazari, O., I
Mahi, D.
Selka, M. A.
Achouri, M. Y.
VALUE IN HEALTH, 2024, 27 (12) : S78 - S78
[15] Pharmacoeconomic analyses using discrete event simulation
J. Jaime Caro
PharmacoEconomics, 2005, 23 : 323 - 332
[16] Common errors and controversies in pharmacoeconomic analyses - Reply
Palmer, S
Byford, S
PHARMACOECONOMICS, 1998, 14 (06) : 712 - 714
[17] Reassessing the Relevance of Pharmacoeconomic Analyses in Formulary Decisions
Jeffrey A. Johnson
Erwin Friesen
PharmacoEconomics, 1998, 13 : 479 - 485
[18] Discounting in pharmacoeconomic analyses: When and how to do it
Basskin, L
FORMULARY, 1996, 31 (12) : 1217 - &
[19] Reassessing the relevance of pharmacoeconomic analyses in formulary decisions
Johnson, JA
Friesen, E
PHARMACOECONOMICS, 1998, 13 (05) : 479 - 485
[20] Marketing science, marketing ourselves
Montgomery, DC
ACADEME-BULLETIN OF THE AAUP, 2003, 89 (05): : 36 - 38

← 1 2 3 4 5 →